Keiretsu Capital — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Blaze Bioscience develops peptide-based fluorescent imaging agents and imaging systems that give surgeons real-time visualization of tumor tissue during cancer surgery.
BiotechHealthtechMedical DevicesSeattle, US
James M. Olson(Director)Steven R. Daly(Executive Officer, Director)inLudmila R. Lobanova(Executive Officer)Julia Novak(Executive Officer)Heather L. Franklin(Director)Dennis M Miller(Executive Officer)
Co-investorsKeiretsu Forum
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.